<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00711360</url>
  </required_header>
  <id_info>
    <org_study_id>TA083</org_study_id>
    <secondary_id>There is no secondary ID</secondary_id>
    <nct_id>NCT00711360</nct_id>
  </id_info>
  <brief_title>Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement (HomeCARE II)</brief_title>
  <acronym>HomeCARE II</acronym>
  <official_title>Monitoring of Fluid Status in Heart Failure Patients by Intrathoracic Impedance Measurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The new BIOTRONIK implantable cardioverter defibrillator (ICD) family Lumax 540 is capable of
      measuring the intrathoracic impedance on a daily basis and transmission of impedance trend
      data via the Home Monitoring technology. In future, this will allow for automatic early
      detection of imminent decompensation at a presymptomatic stage and immediate initialization
      of clinical meaningful therapeutic interventions preventing heart failure related
      hospitalizations. The aim of this investigation is to record long-term impedance trends in
      heart failure patients with and without heart failure related events (hospitalizations due to
      acute decompensation) in order to develop algorithms for device-based early detection and
      warning of HF deterioration accompanied by pulmonary congestion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The new BIOTRONIK implantable cardioverter defibrillator (ICD) family Lumax 540 is capable of
      measuring the intrathoracic impedance on a daily basis and transmission of impedance trend
      data via the Home Monitoring technology. In future, this will allow for automatic early
      detection of imminent decompensation at a presymptomatic stage and immediate initialization
      of clinical meaningful therapeutic interventions preventing heart failure related
      hospitalizations. The aim of this investigation is to record long-term impedance trends in
      heart failure patients with and without heart failure related events (hospitalizations due to
      acute decompensation) in order to develop algorithms for device-based early detection and
      warning of HF deterioration accompanied by pulmonary congestion.

      Lumax is the name of a family of implantable ICDs. The primary objective of the therapy is
      the prevention of sudden cardiac death. The aim is to automatically detect and terminate
      cardiac arrest caused by ventricular tachyarrhythmia. All major therapeutical approaches from
      the field of cardiology and electrophysiology are contained within the Lumax family.

      Furthermore, the device is capable of treating bradycardia arrhythmias and congestive heart
      failure. Congestive heart failure is treated with cardiac resynchronization therapy with
      multisite ventricular pacing known as cardiac resynchronization therapy (CRT).

      The integrated Home Monitoring component can provide information about occurring rhythm
      disturbances and delivered therapies close to real time as well as by intracardiac
      electrogram (IEGM) Online HD®. Furthermore, statistical data about the patient's condition as
      well as information about the integrity status of the implant itself are sent.

      The implantation of an ICD is a symptomatic therapy with the following objectives:

        -  Termination of spontaneous ventricular fibrillation (VF) through shock delivery

        -  Termination of spontaneous ventricular tachycardia (VT) by means of antitachycardia
           pacing (ATP); in case of ineffective ATP or hemodynamically not tolerated VT with shock
           delivery

        -  Cardiac resynchronization by multisite ventricular pacing (triple-chamber implant)

        -  Compensation of bradycardia through ventricular (single-chamber implant) or
           atrioventricular sequential pacing (dual- and triple-chamber implant)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term impedance trends in patients with clinically relevant heart failure events, to support the development of impedance based detection algorithms. A posterior assessment of sensitivity and false alarm rate of the detection algorithms.</measure>
    <time_frame>Study will last until 35 heart failure events are collected</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Further improvement of the Heart Failure Monitor based on collected data</measure>
    <time_frame>The same as for primary outcome measure</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">303</enrollment>
  <condition>Heart Failure</condition>
  <condition>Arrhythmias, Cardiac</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intrathoracic impedance measurement</intervention_name>
    <description>Intrathoracic impedance measurement by cardiac resynchronization therapy (CRT) devices and implantable cardioverter defibrillators (ICDs) (Lumax 540)</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current
             guidelines or patient already implanted with a Lumax 540 device or successor

          -  NYHA-class II to IV

          -  LVEF lower or equal to 35%

          -  Patient accepts Home Monitoring concept and has sufficient GSM/GPRS net coverage

          -  Increased risk for HF-related hospitalization according to pre-defined criteria

          -  Patient information

          -  Informed consent

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  Contraindication for ICD implantation

          -  Post HTX or actively listed for HTX

          -  Cardiac surgery within the previous 3 months or planned at time of inclusion

          -  Acute coronary syndrome within the previous 3 months

          -  Chronic renal dialysis

          -  Pregnant or breast-feeding women

          -  Limited contractual capability

          -  Participation in another study

          -  Anticipated non-compliance with the follow-up scheme

          -  Life expectancy not longer than 1.5 years due to a non-cardiac disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Maier, PD Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Medizinische Klinik und Poliklinik I Universitätsklinikum Würzburg, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RWTH Medizinische Klinik I Aachen</name>
      <address>
        <city>Aachen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik GmbH Bad Nauheim</name>
      <address>
        <city>Bad Nauheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäss-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt a. d. Saale</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HDZ Bad Oeynhausen NRW</name>
      <address>
        <city>Bad Oeynhausen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berufsgenossenschaftliche Kliniken Bergmannsheil Universität Bochum</name>
      <address>
        <city>Bochum</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Erlabrunn gGmbH</name>
      <address>
        <city>Breitenbrunn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ernst-Moritz-Arndt Universität Greifswald</name>
      <address>
        <city>Greifswald</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Hamburg - Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Jena</name>
      <address>
        <city>Jena</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtische Kliniken Neuss -Lukaskrankenhaus- GmbH</name>
      <address>
        <city>Neuss</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marienhospital Osnabrück GmbH</name>
      <address>
        <city>Osnabrück</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marienkrankenhaus Papenburg-Aschendorf GmbH</name>
      <address>
        <city>Papenburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Klinik Saarlouis</name>
      <address>
        <city>Saarlouis</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Evangelischen Diakonissenanstalt</name>
      <address>
        <city>Speyer</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kliniken Villingen</name>
      <address>
        <city>Villingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Würzburg</name>
      <address>
        <city>Würzburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General Yagüe</name>
      <address>
        <city>Burgos</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Donostia</name>
      <address>
        <city>Donostia - San Sebastian</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital General universitario Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardio Centro Ticino</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2008</study_first_submitted>
  <study_first_submitted_qc>July 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2008</study_first_posted>
  <last_update_submitted>September 25, 2012</last_update_submitted>
  <last_update_submitted_qc>September 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>implantable cardioverter-defibrillator</keyword>
  <keyword>intrathoracic impedance</keyword>
  <keyword>cardiac resynchronization therapy</keyword>
  <keyword>home monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

